The American Journal of Managed Care: Key Cost Drivers in Treating Gastroesophageal Cancers Although gastroesophageal reflux disease (GERD) is a disorder of esophageal motility, the therapy of reflux disease is aimed at reducing gastric acidity in order to decrease the injurious effect of ... Gastroesophageal reflux disease is a widespread public health concern. It can lead to the development of Barrett's epithelium, which confers a higher risk of esophageal adenocarcinoma.

Understanding the Context

Surgical ... Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, ... MedPage Today: High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer SAN FRANCISCO -- Three-fourths of patients with unresectable gastroesophageal cancer converted to resectable and had clear margins after treatment with a chemoimmunotherapy combination, a small ...

Key Insights

Medical Xpress: Gastroesophageal reflux disease linked to increased risk for incident acute myocardial infarction Patients with preexisting gastroesophageal reflux disease (GERD) have an increased risk for incident acute myocardial infarction (AMI), according to a study published online Oct. 13 in JGH Open. Gastroesophageal reflux disease linked to increased risk for incident acute myocardial infarction Zanidatamab-containing regimens prolonged progression-free survival (PFS) and overall survival in the first-line setting in patients with HER2-positive locally advanced or metastatic gastroesophageal ...